Strategy’s Stock Soars February, Doubling Bitcoin Gains
Strategy’s stock soared february, jumping 35% from its February low and outpacing bitcoin’s gains as investors price ...
Who Should Open A Roth Ira
Understanding who benefits most from opening a Roth IRA helps you decide if this account fits your retirement strategy and tax outlook.
23,663 articles
Stand with Crypto Stakeholders Pressure Senate Banking
Crypto advocates urge the Senate Banking Committee to protect DeFi protections and stablecoin rewards as hearings app...
Either Trump Lying Other: Markets React to Iran War Claims
Markets react to a high-stakes claim about Iran policy as four living ex-presidents deny involvement. Oil climbs, sto...
Arms Race Shifting Again—These Picks and Shovels Shine
Nvidia signals a wave of AI data-center demand, but investors are eyeing Broadcom and ASML as durable infrastructure ...
Medicare Part Just Crossed $200: What It Means for Retirees
The standard Medicare Part B premium surpassed $200 per month in 2026, up $17.90 from 2025. With COLA growth lagging ...
Benchmark Cuts Price Target for Bakkt by Nearly 50%
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...
Inside Mind of the Active Trader: Leveraged ETFs in Turmoil
As leveraged ETFs surge in popularity, the active trader dominates turnover in these products, reshaping how markets ...
South Korean Lawmakers Push to Abolish 22% Crypto Tax
Seoul lawmakers push to scrap the 22% crypto gains tax slated for 2025, arguing the policy is unfair to everyday inve...
America’s Turning Into European Market Nightmare Deepens
European stocks slump as Middle East tensions lift rate expectations for the ECB and BoE, signaling a new Atlantic ri...
Social Security Years Left: The Tough Fix That Could Pay Off
A new PWBM study places the insolvency deadline for Social Security's trust fund at 2032, six years from now. It eval...
Lamborghini Says ‘Disappointing’ Charging Hampers EV Demand
Lamborghini posts record 2025 deliveries but trims profits as it shelves its all electric Lanzador. The luxury maker ...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status